Annual Long Term Debt
$60.32 M
+$42.79 M+244.10%
December 31, 2023
Summary
- As of February 7, 2025, TRDA annual long term debt is $60.32 million, with the most recent change of +$42.79 million (+244.10%) on December 31, 2023.
- TRDA annual long term debt is now at all-time high.
Performance
TRDA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$53.58 M
-$2.30 M-4.12%
September 30, 2024
Summary
- As of February 7, 2025, TRDA quarterly long term debt is $53.58 million, with the most recent change of -$2.30 million (-4.12%) on September 30, 2024.
- Over the past year, TRDA quarterly long term debt has dropped by -$8.86 million (-14.18%).
- TRDA quarterly long term debt is now -18.36% below its all-time high of $65.62 million, reached on June 30, 2023.
Performance
TRDA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TRDA Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +244.1% | -14.2% |
| 3 y3 years | - | +205.6% |
| 5 y5 years | - | +205.6% |
TRDA Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -18.4% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -18.4% | -100.0% |
| alltime | all time | at high | -100.0% | -18.4% | -100.0% |
Entrada Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $53.58 M(-4.1%) |
| Jun 2024 | - | $55.88 M(-3.9%) |
| Mar 2024 | - | $58.13 M(-3.6%) |
| Dec 2023 | $60.32 M | $60.32 M(-3.4%) |
| Sep 2023 | - | $62.43 M(-4.9%) |
| Jun 2023 | - | $65.62 M(+619.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $9.12 M(-48.0%) |
| Dec 2022 | $17.53 M(>+9900.0%) | $17.53 M(-11.0%) |
| Sep 2022 | - | $19.69 M(-9.7%) |
| Jun 2022 | - | $21.80 M(-8.7%) |
| Mar 2022 | - | $23.89 M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Entrada Therapeutics annual long term debt?
- What is the all time high annual long term debt for Entrada Therapeutics?
- What is Entrada Therapeutics annual long term debt year-on-year change?
- What is Entrada Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly long term debt year-on-year change?
What is Entrada Therapeutics annual long term debt?
The current annual long term debt of TRDA is $60.32 M
What is the all time high annual long term debt for Entrada Therapeutics?
Entrada Therapeutics all-time high annual long term debt is $60.32 M
What is Entrada Therapeutics annual long term debt year-on-year change?
Over the past year, TRDA annual long term debt has changed by +$42.79 M (+244.10%)
What is Entrada Therapeutics quarterly long term debt?
The current quarterly long term debt of TRDA is $53.58 M
What is the all time high quarterly long term debt for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly long term debt is $65.62 M
What is Entrada Therapeutics quarterly long term debt year-on-year change?
Over the past year, TRDA quarterly long term debt has changed by -$8.86 M (-14.18%)